Anti-alfa sinüklein ve anti-tau immünoterapileri: Bir kokteyl yaklaşımı işe yarayabilir mi?
Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?
DOI: 10.1016/j.parkreldis.2024.106080PMID: 38508903
“Parkinson alpha synuclein” Aramayı temizle
Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?
DOI: 10.1016/j.parkreldis.2024.106080PMID: 38508903
MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease.
DOI: 10.1007/s11064-024-04130-yPMID: 38451434
Loss of monomeric alpha-synuclein (synucleinopenia) and the origin of Parkinson's disease.
DOI: 10.1016/j.parkreldis.2024.106077PMID: 38461037
The Alpha-Synuclein Gene (SNCA) is a Genomic Target of Methyl-CpG Binding Protein 2 (MeCP2)-Implications for Parkinson's Disease and Rett Syndrome.
DOI: 10.1007/s12035-024-03974-3PMID: 38429622
Strain-dependent alpha-synuclein spreading in Parkinson's disease and multiple system atrophy.
DOI: 10.4103/nrr.nrr-d-23-01900PMID: 38808991
Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission.
DOI: 10.1038/s41531-024-00650-0PMID: 38368444
Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications.
DOI: 10.1016/j.redox.2024.103092PMID: 38377788
A Surface Imprinted Polymer EIS Sensor for Detecting Alpha-Synuclein, a Parkinson's Disease Biomarker.
DOI: 10.3390/mi15020273PMID: 38399001
Hope vs. Hype I: Spreading alpha-synuclein explains cognitive deficits in Parkinson disease.
DOI: 10.1016/j.parkreldis.2024.106042PMID: 38365523
Reduction of alpha-synuclein oligomers in preclinical models of Parkinson's disease by electrical stimulation in vitro and deep brain stimulation in vivo.
DOI: 10.1016/j.brs.2024.02.005PMID: 38342364
MUFA synthesis and stearoyl-CoA desaturase as a new pharmacological target for modulation of lipid and alpha-synuclein interaction against Parkinson's disease synucleinopathy.
DOI: 10.1016/j.neuropharm.2024.109865PMID: 38342377
An innovative method for the detection of alpha synuclein, a potential biomarker of Parkinson's disease: quartz tuning fork-based mass sensitive immunosensor design.
DOI: 10.1039/d3cp04527gPMID: 38259152
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.